Image showing a PICO summary for:
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
by Lee et al.
featured in the Stem Cell Evidence Alert - October 2025
New from #StemCellEvidence:
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
by Lee et al.
www.stemcellevidence.com/articles/409...
#MedSky
07.11.2025 13:10 — 👍 0 🔁 1 💬 0 📌 0
The new Cochrane Library homepage is live!
Find trusted evidence faster, whether you’re researching, teaching, or making clinical decisions.
Explore now: www.cochranelibrary.com
06.11.2025 13:56 — 👍 2 🔁 3 💬 0 📌 0
Image showing a PICO summary for:
Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study
by Kogler et al.
featured in the Stem Cell Evidence Alert - October 2025
From the #StemCellEvidence Alert:
Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study
by Kogler et al.
www.stemcellevidence.com/articles/409...
#MedSky
06.11.2025 14:06 — 👍 3 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Carbapenemase-Producing Enterobacteriaceae Colonization and the Risk of Carbapenemase-Producing Enterobacteriaceae Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by Kang et al.
featured in the Stem Cell Evidence Alert - October 2025
New from #StemCellEvidence:
Carbapenemase-Producing Enterobacteriaceae Colonization and the Risk of Carbapenemase-Producing Enterobacteriaceae Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by Kang et al.
www.stemcellevidence.com/articles/409...
#MedSky
05.11.2025 07:36 — 👍 0 🔁 0 💬 0 📌 0
Image showing a PICO summary for:
Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial
by Teofili et al.
featured in the Transfusion Evidence Alert - October 2025
From the #Transfusion Evidence Alert:
Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial
by Teofili et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
04.11.2025 10:19 — 👍 1 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation
by Fujii et al.
featured in the Stem Cell Evidence Alert - October 2025
From the #StemCellEvidence Alert:
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation
by Fujii et al.
www.stemcellevidence.com/articles/409...
#MedSky
04.11.2025 10:27 — 👍 0 🔁 0 💬 0 📌 0
Image showing a PICO summary for:
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
featured in the Stem Cell Evidence Alert - October 2025
New from #StemCellEvidence:
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
03.11.2025 09:43 — 👍 3 🔁 2 💬 0 📌 0
Image showing a PICO summary for:
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry
by Cohen et al.
featured in the Stem Cell Evidence Alert - October 2025
From the #StemCellEvidence Alert:
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry
by Cohen et al.
www.stemcellevidence.com/articles/408...
#MedSky
31.10.2025 10:43 — 👍 0 🔁 0 💬 0 📌 0
Image showing a PICO summary for:
Viscoelastic testing in postpartum obstetric hemorrhage: a scoping review commissioned by the Patient-Centered Outcomes Research Institute (PCORI)
by Janzen et al.
featured in the Transfusion Evidence Alert - October 2025
From the #Transfusion Evidence Alert:
Viscoelastic testing in postpartum obstetric hemorrhage: a scoping review commissioned by the Patient-Centered Outcomes Research Institute (PCORI)
by Janzen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
31.10.2025 10:37 — 👍 1 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
by Balduzzi et al.
featured in the Stem Cell Evidence Alert - October 2025
New from #StemCellEvidence:
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
by Balduzzi et al.
www.stemcellevidence.com/articles/408...
#MedSky
30.10.2025 08:30 — 👍 1 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI)
by Clark et al.
featured in the Stem Cell Evidence Alert - October 2025
From the #StemCellEvidence Alert:
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT) (...)
by Clark et al.
www.stemcellevidence.com/articles/409...
#MedSky
29.10.2025 07:33 — 👍 3 🔁 0 💬 0 📌 0
Image showing a PICO summary for:
Evaluating Economic and Clinical Impacts of Anaemia Management Strategies: A #SystematicReview of the Evidence From the UK Perspective
by Farabi et al.
featured in the Transfusion Evidence Alert - October 2025
From the #Transfusion Evidence Alert:
Evaluating Economic and Clinical Impacts of Anaemia Management Strategies: A #SystematicReview of the Evidence From the UK Perspective
by Farabi et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
29.10.2025 07:22 — 👍 3 🔁 1 💬 0 📌 0
Image of an extract of the Stem Cell Evidence Alert - October 2025
The #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
28.10.2025 15:34 — 👍 0 🔁 0 💬 0 📌 0
Image showing a PICO summary for:
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation: A Real-World Study
by Sun et al.
featured in the Stem Cell Evidence Alert - September 2025
From the #StemCellEvidence Alert:
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation (...)
by Sun et al.
www.stemcellevidence.com/articles/408...
#MedSky
13.10.2025 08:55 — 👍 2 🔁 2 💬 0 📌 0
Image showing a PICO summary for:
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis
by Yang et al.
featured in the Transfusion Evidence Alert - September 2025
New from #Transfusion Evidence Library:
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
10.10.2025 12:13 — 👍 3 🔁 2 💬 0 📌 0
Image showing a PICO summary for:
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
featured in the Stem Cell Evidence Alert - September 2025
New from #StemCellEvidence:
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
10.10.2025 12:32 — 👍 1 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants
by Saliba et al.
featured in the Stem Cell Evidence Alert - September 2025
New from #StemCellEvidence:
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants
by Saliba et al.
www.stemcellevidence.com/articles/407...
#MedSky
09.10.2025 11:42 — 👍 3 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial
by Robin et al.
featured in the Stem Cell Evidence Alert - September 2025
New from #StemCellEvidence:
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (...)
by Robin et al.
www.stemcellevidence.com/articles/407...
#MedSky
08.10.2025 09:18 — 👍 0 🔁 0 💬 0 📌 0
Image showing a PICO summary for:
Neurological manifestations of chronic graft versus host disease
by Koren et al.
featured in the Stem Cell Evidence Alert - September 2025
From the #StemCellEvidence Alert:
Neurological manifestations of chronic graft versus host disease
by Koren et al.
www.stemcellevidence.com/articles/408...
#MedSky
07.10.2025 06:38 — 👍 1 🔁 2 💬 0 📌 0
Image showing a PICO summary for:
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
by Hernández-Boluda et al.
featured in the Stem Cell Evidence Alert - September 2025
New from #StemCellEvidence:
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
by Hernández-Boluda et al.
www.stemcellevidence.com/articles/408...
#MedSky
06.10.2025 08:51 — 👍 0 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes
by Karakas et al.
featured in the Transfusion Evidence Alert - September 2025
New from #Transfusion Evidence Library:
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes
by Karakas et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
06.10.2025 08:47 — 👍 1 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation
by Capes et al.
featured in the Stem Cell Evidence Alert - September 2025
From the #StemCellEvidence Alert:
Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood (...)
by Capes et al.
www.stemcellevidence.com/articles/407...
#MedSky
03.10.2025 11:03 — 👍 0 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers
by Caballero-Velázquez et al.
featured in the Stem Cell Evidence Alert - September 2025
From the #StemCellEvidence Alert:
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers
by Caballero-Velázquez et al.
www.stemcellevidence.com/articles/407...
#MedSky
02.10.2025 06:30 — 👍 1 🔁 2 💬 0 📌 0
Image showing a PICO summary for:
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party
by Berning et al.
featured in the Stem Cell Evidence Alert - September 2025
New from #StemCellEvidence:
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party
by Berning et al.
www.stemcellevidence.com/articles/408...
#MedSky
01.10.2025 08:11 — 👍 0 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial
by Stelljes et al.
featured in the Stem Cell Evidence Alert - September 2025
From the #StemCellEvidence Alert:
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial
by Stelljes et al.
www.stemcellevidence.com/articles/407...
#MedSky
30.09.2025 09:56 — 👍 1 🔁 2 💬 0 📌 0
Image showing a PICO summary for:
#Tranexamicacid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial
by the TREATT Trial Investigators
featured in the Transfusion Evidence Round-Up: Blood Cancer Awareness Month 2025
From the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025
#Tranexamicacid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (...)
by the TREATT Trial Investigators
www.transfusionevidencelibrary.com/articles/396...
#MedSky
30.09.2025 09:39 — 👍 1 🔁 1 💬 0 📌 0
Image showing an extract of the Stem Cell Evidence Alert - September 2025
The #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
29.09.2025 09:21 — 👍 1 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews
by He et al.
featured in the Transfusion Evidence Round-Up: Blood Cancer Awareness Month 2025
New from the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025
Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews
by He et al.
www.stemcellevidence.com/articles/362...
#MedSky @isbt.bsky.social @stemcellevidence.bsky.social
25.09.2025 13:27 — 👍 1 🔁 1 💬 0 📌 0
Image showing a PICO summary for:
The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A #SystematicReview and #MetaAnalysis
by Chen et al.
featured in the Transfusion Evidence Round-Up: Blood Cancer Awareness Month 2025
New from the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025
The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A #SystematicReview and #MetaAnalysis
by Chen et al.
www.stemcellevidence.com/articles/387...
#MedSky
23.09.2025 13:16 — 👍 2 🔁 2 💬 0 📌 0
Image showing a PICO summary for:
Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial
by Garcia-Manero et al.
featured in the Transfusion Evidence Round-UP: Blood Cancer Awareness Month 2025
From the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025
Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa (...)
by Garcia-Manero et al.
www.transfusionevidencelibrary.com/articles/403...
#MedSky
24.09.2025 09:16 — 👍 3 🔁 2 💬 0 📌 0
The BMJ is patient centred, evidence based, and independent. Help us improve the health of our world with the best science, journalism, education, and comment.
JAMA is an international peer-reviewed general medical journal and a member of the JAMA Network family of journals.
🌐 JAMA.com
Trusted evidence. Informed decisions. Better health.
We're new here! 👋
Cochrane is a global independent group of researchers, professionals, patients, careers, and people interested in health. We are the US network!
Learn about our group here👉 https://us.cochrane.org/news
Welcome to the official Bluesky account for the New England Journal of Medicine. Follow for high-quality, peer-reviewed research and clinical content from the world’s leading medical journal, online at NEJM.org.
Follow @ai.nejm.org for medical AI content.
JBI is a global organisation that promotes and supports evidence-informed decisions to improve health and health service delivery. Find us at jbi.global
PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy and practice.
Welcome to Wiley. We're a trusted leader in research and learning, empowering innovators to publish and advance discoveries, evolve workforces and shape minds.
The Royal Society is a Fellowship of many of the world's most eminent scientists and is the oldest scientific academy in continuous existence.
The Royal Society of Medicine is a leading provider of continuing learning to healthcare professionals. Our vision: better healthcare for better lives.
Ensuring NHS Scotland provides the best environment to support clinical research so patients can benefit from new and better treatments. https://www.nhsresearchscotland.org.uk/
We are an independent charity that supports, promotes and represents public libraries. Our work is driven and led by our membership, which includes almost every library service in England, Wales, Northern Ireland and the Crown Dependencies.
A student-run society at the University of Oxford, dedicated to improving access to skills and careers in science communication. Find out more at ossce.org.uk
The NIHR Oxford Biomedical Research Centre (BRC) is a collaboration between the University of Oxford and Oxford University Hospitals NHS Foundation Trust to fund medical research.
Connecting researchers & staff @ox.ac.uk with those who share our vision of public policy powered by the best available evidence & expertise.
Cell Reprogramming in Hematopoiesis and Immunity, Lund University, Sweden. Tweets by Filipe Pereira (signed FP) and Malavika Nair (for Pereira lab). https://pereiralab.com/
Generating real world evidence in blood cancer using national NHS datasets.
A platform for life sciences. Publications, research protocols, news, events, jobs and more. Sign up at https://www.lifescience.net.
Global researcher & practitioner network based at The University of Queensland (UQ). Promotes donor research to health sector & community. Website: research.psy.uq.edu.au/dorn/
UQ Social Media Guidelines: http://bit.ly/3Cruuly
Co-Creating Ireland's Public Involvement in Open Research Roadmap
ENGAGED is building a national roadmap to shape public involvement in open research in Ireland. We believe that research can and does play an important role in tackling societal challenges.
